nigericin has been researched along with dehydrocostus lactone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, Y; Bai, Z; Chen, Y; Hou, X; Li, R; Shi, W; Sun, H; Wang, C; Wang, JB; Wang, Z; Xiao, X; Xu, G; Zhan, X | 1 |
1 other study(ies) available for nigericin and dehydrocostus lactone
| Article | Year |
|---|---|
Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivo.
Topics: Adult; Animals; Apoptosis Regulatory Proteins; Calcium-Binding Proteins; CARD Signaling Adaptor Proteins; Caspase 1; Chemotaxis, Leukocyte; DNA-Binding Proteins; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Female; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Lactones; Leukocytes, Mononuclear; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Poly I-C; Polymerization; Sesquiterpenes; Specific Pathogen-Free Organisms; Uric Acid | 2020 |